OKLO and IonQ: Two Pre-Revenue Bets on the 2030s
On April 24, OKLO touched $81.50. Three weeks earlier it had been at $48.
The same month, IonQ ran 56.5% — its biggest monthly gain in over a year. Two of the most speculative names in my portfolio both went vertical in the same four-week window, and neither company has meaningful revenue yet.
That's worth sitting with.
I don't own these stocks because the next quarter looks good. I own them because I think the world that exists in 2032 needs cheap, scalable nuclear power and at least one company that has cracked fault-tolerant quantum computing — and I'd rather be early and wrong than late and right.
I put $25 a week into each, $50 total, and I keep buying whether the chart is green or red. This post is me explaining to myself why.
OKLO is a bet that small reactors will get built this time
The pitch is straightforward: AI data centers need enormous, reliable, carbon-free power, and the grid can't deliver it on the timeline anyone wants.
Oklo is building Aurora, a 75-megawatt liquid-metal-cooled fast reactor designed to be factory-built and sited next to the customer — a hyperscaler, a defense base, an industrial park. The first one is targeted to come online at Idaho National Laboratory in 2027 or 2028.
The April 2026 rally wasn't random. The U.S. Energy Secretary confirmed DOE loan support for the first batch of new advanced reactors. HSBC initiated coverage with a Buy and a $96 target. Oklo was named to the federal Genesis Mission alongside Nvidia and Los Alamos National Laboratory — the kind of partnership that doesn't happen by accident. Tigress Financial set an even higher $130 target.
Three real catalysts in three weeks, in a stock with a tight float and a rabid retail base, gets you a 50% move.
The numbers underneath that move are sobering. Oklo posted a 2025 operating loss of $139.3 million, missed Q4 EPS estimates by 63%, and made zero revenue.
It has roughly $1.2–$1.4 billion in cash and no debt, which is enough runway. But at a $6.5 billion market cap the stock is priced for a 2027 commissioning that goes flawlessly, customer contracts that materialize on schedule, and an NRC that doesn't add a year of delay.
Insiders sold something like $93 million of stock in the three months leading into the rally, which is its own signal.
If I'm wrong about Oklo, I'm wrong because the first Aurora slips to 2029, the AI capex cycle softens before the reactors are ready, and a competitor — NuScale, X-energy, TerraPower, one of the SMR startups still private — gets to scale first. The stock probably retraces to the $40s.
If I'm right, Oklo is selling reactors to every hyperscaler that has run out of substations to plug into.
IonQ is a bet that trapped-ion quantum will scale before superconductors do
Quantum computing has been "five years away" for fifteen years.
What changed in April is that IonQ did two things in a single day. On April 14, the company demonstrated photonic entanglement between two separate commercial trapped-ion systems — the first time anyone has connected two production quantum computers and had them behave like one larger machine. The same day, DARPA selected IonQ for its Heterogeneous Architectures for Quantum (HARQ) program.
The stock closed up 18% on the day and ran another 38% across the rest of the month.
The financials are better than OKLO's, though "better" is doing a lot of work. Q4 2025 revenue came in at $61.9 million — up 429% year over year and a 54% beat on consensus. Full-year 2026 guidance is $225–$245 million, with the pending SkyWater acquisition not yet baked in.
That's real revenue growth. It's also accompanied by a $229 million quarterly operating loss, which tells you exactly how much money quantum hardware costs to build.
The bull case for IonQ is that trapped-ion qubits — atoms held in place by lasers in a vacuum chamber — have inherently better fidelity than the superconducting qubits IBM and Google are betting on. The photonic-interconnect breakthrough means IonQ can scale by linking smaller, high-quality systems instead of trying to build one giant chip.
If quantum networking is how this technology actually arrives, IonQ is two years ahead.
The bear case is that "better fidelity" doesn't matter if Google's superconducting roadmap gets to a million logical qubits first. That 23% of the float was still being shorted as of mid-April for good reason. And the entire commercial market for quantum compute today is small enough to fit in a rounding error on AWS's earnings call.
The stock has already round-tripped from an all-time high to nearly half of it once this cycle. It will probably do it again.
Why DCA into both, and why $25 each
I don't know which of these bets is right. I think there's a reasonable chance one of them is wrong by 70%, and a reasonable chance the other is up 5x in five years.
Equal weighting is honesty about the fact that I can't tell which is which.
Splitting it $25/$25 instead of tiering — the way I split Circle and CoreWeave — is intentional. Circle had revenue. CoreWeave had revenue and a $55 billion backlog. I could rank them on financial reality.
OKLO and IonQ are both essentially science projects with public tickers. Ranking them feels like false precision.
The math is what does the work. Here's what $25/week into OKLO would have looked like across a hypothetical four-week stretch in this kind of volatility:
| Week | Price | Shares Bought |
|---|---|---|
| 1 | $74 | 0.34 |
| 2 | $62 | 0.40 |
| 3 | $48 | 0.52 |
| 4 | $68 | 0.37 |
Same dynamic on IONQ at $44 → $32 → $28 → $38: volatility you can't control becomes cost-basis you can.
Over a 12–18 month horizon, the average price I pay will be lower than whatever the chart looks like at any single moment, and I will not be the person who panic-sold at the bottom because I will have bought more there.
What would change my mind
For OKLO: a serious NRC delay on the Aurora design certification, a major customer (the Air Force pilot, the data-center anchor) walking away, or another SMR company commissioning a reactor first.
For IonQ: a Q1 2026 print outside the $48–51 million guidance range, the SkyWater deal hitting regulatory trouble, or — most importantly — a credible superconducting-qubit milestone from Google or IBM that makes the trapped-ion approach look like the wrong horse.
If none of those happen, I just keep buying.
$50 a week is small enough that being wrong doesn't hurt and big enough that being right matters. That's the only sweet spot I trust with stocks like these.
---
This is not financial advice. I own both OKLO and IONQ. I'm sharing my personal research and strategy. Always do your own due diligence before investing.